Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$105.24 USD
-0.72 (-0.68%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $97.90 -7.34 (-6.97%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth D Momentum C VGM
Price, Consensus and EPS Surprise
ABT 105.24 -0.72(-0.68%)
Will ABT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ABT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ABT
Integer Holdings (ITGR) Q2 Earnings Top Estimates, Margins Up
ICON (ICLR) Q2 Earnings Surpass Estimates, Margins Expand
ABT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amedisys (AMED) Q2 Earnings Top Estimates, Gross Margin Down
The Zacks Analyst Blog Highlights SAP, Abbott Laboratories, Citigroup, Team and Vaso
Align Technology (ALGN) Beats on Q2 Earnings, Lowers '24 Sales View
Other News for ABT
DexCom Q2: Surprising Earnings Miss With Hints Of Competitive Pressures
Peering Into Abbott Laboratories's Recent Short Interest
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?
Abbott Labs falls after jury awards plaintiff $495M in damages in baby formula case (update)
Abbott Labs falls after jury awards plaintiff $95M in damages in baby formula case